Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 10

1.

High-affinity inhibitors of human NAD-dependent 15-hydroxyprostaglandin dehydrogenase: mechanisms of inhibition and structure-activity relationships.

Niesen FH, Schultz L, Jadhav A, Bhatia C, Guo K, Maloney DJ, Pilka ES, Wang M, Oppermann U, Heightman TD, Simeonov A.

PLoS One. 2010 Nov 2;5(11):e13719. doi: 10.1371/journal.pone.0013719.

2.

Potent and selective inhibitors of NAD+-dependent 15-hydroxyprostaglandin dehydrogenase (HPGD).

Jadhav A, Niesen FH, Schultz L, Oppermann U, Maloney DJ, Simeonov A.

Probe Reports from the NIH Molecular Libraries Program [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2010-.
2010 Mar 4 [updated 2011 Mar 11].

3.

NAD+-linked 15-hydroxyprostaglandin dehydrogenase: structure and biological functions.

Tai HH, Cho H, Tong M, Ding Y.

Curr Pharm Des. 2006;12(8):955-62. Review.

PMID:
16533162
4.

15-Hydroxyprostaglandin dehydrogenase.

Ensor CM, Tai HH.

J Lipid Mediat Cell Signal. 1995 Oct;12(2-3):313-9. Review.

PMID:
8777575
5.

Inhibitors of type 5 17β-hydroxysteroid dehydrogenase (AKR1C3): overview and structural insights.

Byrns MC, Jin Y, Penning TM.

J Steroid Biochem Mol Biol. 2011 May;125(1-2):95-104. doi: 10.1016/j.jsbmb.2010.11.004. Review.

6.

Regulation of 15-hydroxyprostaglandin dehydrogenase (15-PGDH) by non-steroidal anti-inflammatory drugs (NSAIDs).

Tai HH, Chi X, Tong M.

Prostaglandins Other Lipid Mediat. 2011 Nov;96(1-4):37-40. doi: 10.1016/j.prostaglandins.2011.06.005. Review.

PMID:
21763448
7.

Prostaglandin catabolizing enzymes.

Tai HH, Ensor CM, Tong M, Zhou H, Yan F.

Prostaglandins Other Lipid Mediat. 2002 Aug;68-69:483-93. Review.

PMID:
12432938
8.

15-hydroxyprostaglandin dehydrogenase (15-PGDH) and lung cancer.

Tai HH, Tong M, Ding Y.

Prostaglandins Other Lipid Mediat. 2007 May;83(3):203-8. Review.

9.

Prostaglandin catabolic enzymes as tumor suppressors.

Tai HH.

Cancer Metastasis Rev. 2011 Dec;30(3-4):409-17. doi: 10.1007/s10555-011-9314-z. Review.

PMID:
22020925
10.

Multiple drug resistance-associated protein 4 (MRP4), prostaglandin transporter (PGT), and 15-hydroxyprostaglandin dehydrogenase (15-PGDH) as determinants of PGE2 levels in cancer.

Kochel TJ, Fulton AM.

Prostaglandins Other Lipid Mediat. 2015 Jan-Mar;116-117:99-103. doi: 10.1016/j.prostaglandins.2014.11.003. Review.

Items per page

Supplemental Content

Support Center